Commercialisation potential of Tetradenia riparia (Hochst.) Codd: A review based on traditional uses and scientific validation

Abstract

Background: Globally, medicinal plants and their health-related products provide significant income and are recognised as important contributors to livelihoods. There still exist challenges in the commercialisation of certain medicinal plants over others. A medicinal plant widely used by indigenous African communities, Tetradenia riparia (Hochst.) Codd presents strong potential for large-scale commercialisation. Despite its widespread use, limited data exist on the potential impact of commercialising T. riparia.
Aim: This review explores the commercialisation potential of T. riparia by highlighting its traditional uses, scientific validation, possible commercialisation prospects and opportunities for economic growth and product development.
Setting: The review draws on peer-reviewed scientific literature to assess the status of the plant and its potential role in both local and global markets.
Method: A systematic literature review was conducted using targeted search terms related to the commercialisation of medicinal plants and T. riparia. Relevant publications were screened by title, abstract and full text, and the most appropriate studies were analysed to provide insights into the plant’s commercialisation potential.
Results: Findings reveal that T. riparia is a promising medicinal plant with significant commercialisation prospects. In addition to its role as an alternative medicine for various health conditions, the plant demonstrates potential in other markets, including food supplements, oral care products, natural pesticides and food preservation.
Conclusion: This review highlights the medicinal significance of T. riparia (Hochst.) Codd (T. riparia), emphasising its scientifically validated therapeutic potential and diverse market opportunities.
Contribution: This study contributes to the growing body of knowledge on the potential of T. riparia (Hochst.) Codd.